Mark Lemley’s amicus brief was discussed by Patent Docs in “Patent Law Academics File Amicus Brief in Amgen v. Sanofi”.

The professors’ arguments, by lead author Mark Lemley of Stanford University, rely heavily on the late Dmitriy Karshtedt’s paper entitled The Death of Genus Claims (Dmitry Karshtedt, Mark A. Lemley & Sean B. Seymore, The Death of the Genus Claim, 35 HARV. J. L. & TECH. 1, 23-35 (2021). “The central feature of patent law in the life sciences industries is the genus claim” is the first assertion in the brief.